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Optical microscopy and atomic force microscopy (AFM) make
a powerful combination for the investigation of bio-materials, be-
cause the optical overview, ﬂuorescence or spectroscopy informa-
tion can be combined with the nano-imaging and nano-manipulation
capabilities of the AFM. Previously this combination was mainly
limited to transparent samples, where the AFM could measure from
above simultaneously with an inverted optical microscope from
below the sample.
JPK has developed a novel approach to allow the combination of
upright microsocpy with AFM on the same sample region, so that
non-transparent samples, including ceramic or metallic materials,
can be used. A patented calibration procedure ensures that the
region of interest can be found and re-imaged with micron preci-
sion, so now exactly the same area can be sequentially measured
optically and with AFM. The JPK BioMaterialsWorkstation en-
ables the full capabilities of advanced upright optical microscopy,
including ﬂuorescence techniques, immersion lenses and confocal
laser scanning. This is combined with the AFM for high resolution
nano-imaging, elasticity and adhesion measurements, as well as
nano-manipulation and lithography. In particular, measurements
with high resolution dipping lenses and AFM measurements in
liquid become possible on the same sample area.
These capabilities open new possibilities for the investigation of
bio-ﬁlm formation, biocompatible materials, cell growth on scaf-
folds and many more biomaterials measurements.
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Recent studies have shown that culturing undifferentiated stem
cells in appropriate biochemical environments and under me-
chanical stimulation could provide the correct signals for cellular
proliferation, differentiation and subsequent extracellular matrix
production. This triggered a growing interest about in vitro bio-
mechanically-stimulating culture environments.
Themain goal of this work was to evaluate the efﬁcacy of a newly
developed bidirectional perfusion bioreactor. This apparatus en-
ables implementing complex culturing programmes. Both perfusion
ﬂow rate and direction can be varied along the culturing period. This
compact and user-friendly system is made of autoclavable materi-
als enabling to culture up to 20 samples simultaneously. This study
aimed at determining the most effective programmes for enhance-
ment of cellular proliferation and differentiation. Fiber-bonded
starch polycaprolactone (SPCL) meshes were statically seeded with
goat bone marrow cells (GBMCs). These meshes were cultured ei-
ther statically or under several dynamic culturing programmes for 7
and 14 days. Collected samples were characterized by DNA and
alkaline phosphatase (ALP) quantiﬁcation and scanning electronic
microscopy (SEM). DNA quantiﬁcation results showed a tendency
for greater cellular proliferation under static and unidirectional per-
fusion conditions. ALP activity results revealed an enhanced cellular
differentiation rate under cyclic ﬂow direction inversion. SEM re-
sults also showed greater cellular adherence and spreading in cell-
scaffold hybrid constructs cultured under those conditions. In
conclusion, this culture system can be used for enhancing cellular
proliferation and differentiation by optimizing the combination of
ﬂuid ﬂow rate and ﬂow inversion frequency during culturing periods.
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Several studies in the last years have shown the insulin indepen-
dence achieved by intraportal islet transplantation in patients with
type I diabetes. However, long-term results have indicated that the
site and method of transplantation still need to be optimized to
improve islet engraftment. The subcutaneous space has been
widely assessed as a simple and safe alternative to the liver.
Nevertheless, the sparse vascularization of this space is the main
limitation for its use as an islet transplantation site. To overcome
this drawback, new strategies have focused on the use of pro-
angiogenic growth factors to enhance vascularization and on the
use of different biomaterials as islet scaffolds. In this study we used
plasma, obtained by directly centrifuging donor’s blood, as scaf-
fold, and ﬁbroblasts, isolated from donor’s skin biopsies, as the
source of pro-angiogenic factors. Cultured ﬁbroblasts were re-
suspended in plasma containing tranexamid acid. Next, fresh iso-
lated islets were added to the mixture and coagulation was induced
by CaCl2, such that pro-coagulant factors such as thrombin were
not necessary. Islets embedded in this ‘‘plasma-ﬁbroblast gel’’ were
transplanted subcutaneously in STZ-induced diabetic mice and
compared with diabetic mice transplanted with free islets beneath
the kidney capsule (control) and with normal mice. Our ﬁndings
indicate that subcutaneous transplantation of pancreatic islets em-
bedded in a plasma-ﬁbroblast gel reverts type I diabetes in mice
similarly to the standard procedure. This approach could be a useful
and safe option to treat this disease in human clinical practice.
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